Slingshot members are tracking this event:
Ipsen Announces FDA Approval of Dysport (abobotulinumtoxinA) for injection for the treatment of Lower Limb Spasticity in children aged two and older
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Aug 01, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Dysport, Abobutulinumtoxina, Abobotulinumtoxina, Lower Limb Spasticity